OncoOne
PrivateLast Round
Series B
Apr 1, 2022
Total Funding Raised
$14.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoOne is a biotechnology company that develops precision medicines for cancer and chronic inflammatory diseases using its proprietary antibody-based targeting platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoOne Comparables
Compare OncoOne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreTT ApS | 78% | |
| Y-mAbs Therapeutics | 76% | |
| Akiram Therapeutics | 76% |
OncoOne Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
OncoOne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Series A |
| FFG Austrian Research Promotion Agency | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 349% MoM, from 243 to 1.1K.
- May 14, 2026
Monthly visitors grew 68% MoM.
OncoOne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoOne's valuation, stock price, and market status.
Is OncoOne a public or private company?
OncoOne is a private company.
What is the current stock price of OncoOne?
OncoOne is a private company, so its shares have no public market price. Caplight tracks OncoOne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoOne worth (valuation)?
Valuation information for OncoOne is not publicly available.
Can I buy OncoOne stock?
OncoOne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoOne's last funding round?
OncoOne's most recent funding round was Series B on April 1, 2022.
Who are the main investors in OncoOne?
Key investors in OncoOne include Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.
Will OncoOne IPO soon?
No public IPO plans have been announced for OncoOne.
How can I track OncoOne secondary market activity?
Caplight tracks bids, offers, and trades in OncoOne's shares on secondary markets.